Background: Despite an increasing incidence of venous thromboembolism (VTE) in pediatric
patients in tertiary care settings, relatively few pediatric physicians have experience with …

Kaposiform hemangioendothelioma (KHE) is a rare, potentially life-threatening vascular tumor
often associated with a coagulopathy known as Kasabach–Merritt phenomenon (KMP). 1 …

Pulmonary embolism (PE) is rare in childhood but evidence suggests it is under‐recognised.
Children diagnosed with PE at a large tertiary centre over an 8‐year period were …

Background— Thrombosis, usually considered a serious but rare complication of pediatric
cardiac surgery, has not been a major clinical and/or research focus in the past. Methods and …

Background Dabigatran etexilate is a direct oral anticoagulant with potential to overcome
the limitations of standard of care in children with venous thromboembolism. The aims of this …

Although genetic and environmental factors explain approximately half of the interindividual
variability in warfarin dose requirement in adults, there is limited information available in …

Importance Among patients younger than 21 years of age, the optimal duration of anticoagulant
therapy for venous thromboembolism is unknown. Objective To test the hypothesis that a …

Prior criteria for organ dysfunction in critically ill children were based mainly on expert
opinion. We convened the Pediatric Organ Dysfunction Information Update Mandate (PODIUM) …

OBJECTIVES: To describe the incidence of thrombotic complications across all 3 stages of
single ventricle palliation and the association between thromboprophylaxis use and …

This open-label, single-arm, prospective cohort trial is the first phase 3 safety study to
describe outcomes in children treated with dabigatran etexilate for secondary venous …